StemCell Therapy

The global lutein market was calculated to be worth $274.6 million in the year 2018, and is projected to be valued at $454.8 million by the year 2026, delivering a CAGR of 6.4 per cent in that duration.

The rising incidences of cataract and age-related macular degeneration (AMD) have influenced the demand for lutein.

The fact that lutein is beneficial for the eyes and can protect and maintain healthy cells in the eyes, especially with our ever-increasing exposure to blue light, has led to the increased adoption of lutein supplements, and will subsequently bring to light more growth opportunities.

Lutein, an antioxidant carotenoid, is one of the two essential carotenoids that act as colour pigments in the human eye, and also gives the yellow colour to fruits and vegetables. In the eye, it acts as a light filter and prevents the eye tissues against damages caused by sunlight.

This article has been designed to encompass all vital aspects of the lutein industry that influence the growth of the sector. The companies functioning in the sector are undertaking strategic initiatives to gain a competitive advantage against all rival companies.

The major companies operating in the industry are Allied Biotech, BASF, Chr. Hansen, Dhler, DDW The Color House, E I D Parry, Fenchem, Lycored, PIVEG, and Zhejiang Medicine.

Back in 2015, DSM and Kemin had extended their partnership, launching FloraGlo Lutein, an eye health solution suitable for effective eye health ingredients.

In September 2019, the US-based company EyePromise debuted Screen Shield Pro as the latest addition to its eye vitamin range.

The product has been created with lutein and naturally-derived zeaxanthin to help prevent the eyes from damage caused by screens.

Based on form, lutein is mainly available in the forms of powder and crystalline, oil suspension, beadlet, and emulsion, whereas based on source, lutein is derived from natural as well as synthetic sources, and have major applications in the food and beverages sector.

Based on source, natural lutein is estimated to achieve a sizable growth due to the health benefits it offers.

However, synthetic lutein will dominate the market as it is easy to manufacture and are cost comparatively less than natural lutein.

The integration of lutein into dietary supplements will account for 27.4 per cent of the global market share.

Lutein has found extensive usage in eye care supplements and can also effectively prevent breast cancer, colon cancer, type 2 diabetes, and heart diseases.

The market extends to five major regions across the globe, viz., North America, Europe, Asia Pacific, Latin America, and the Middle-East and Africa.

Reports and Data estimates that the lutein market in the North American region will control the biggest portion of the global industry, and the Asia Pacific market will register the highest growth rate of 8.2 per cent in the forecast duration between 2020 and 2026.

The rising incidences of cataract and AMD in the region will drive the demand for the product in the region.

Data from the American Academy of Opthalmology indicates that nearly 24.4 million Americans aged 40 and older are affected by cataract, while almost 2.1 million Americans over 50 have late AMD, which leads to severe vision impairment.

Overall, the global lutein market exhibits tremendous growth potential for this decade, primarily originating from the increasing awareness among the population regarding the numerous health benefits of consuming lutein.

Read more:
Lutein mkt projected to be valued at $454.8 mn by '26, growing at 6.4% | FNB News - fnbnews.com

This entry was posted on February 13, 2020 at 12:48 pm and is filed under Opthalmology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |